Skip to main content
. 2022 Oct 17;13:1026070. doi: 10.3389/fimmu.2022.1026070

Figure 3.

Figure 3

Schematic summary of microbial translocation, immune cells involved, and altered circulating markers in UCs, IRs, and INRs. UCs, uninfected controls; IRs, immune responders; INRs, immune non-responders; SCFA, short chain fatty acids; sCD14, soluble CD14; sCD163, soluble CD163; IL-6, interleukin-6; IL-7, interleukin-7; IL-7R, interleukin-7 receptor; IL-1α, interleukin-1α; IL-1β, interleukin-1β; IL-8, interleukin-8; IL-18, interleukin-18; IP-10, interferon-inducible protein 10; LPS, lipopolysaccharide; hsCRP, hypersensitive C-reactive protein; TGF-β, transforming growth factor-β; VCAM, vascular adhesion molecules; HA, hyaluronic acid; CXCL4, C-X-C motif chemokine ligand 4; MC, myristyl carnitine; PC, palmitoylcarnitine; SC, stearoylcarnitine; OC, oleoylcarnitine; ↑, increase in comparison with uninfected controls; ↓, decrease in comparison with uninfected controls.